Apidra (Type 2 Diabetes)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
3 Disease Overview 13
3.1 Etiology and Pathophysiology 13
3.1.1 Etiology 13
3.1.2 Pathophysiology 14
3.1.3 Prognosis 15
3.1.4 Quality of Life 16
3.2 Symptoms 16
4 Disease Management 18
4.1 Treatment Overview 18
4.1.1 Diagnosis and Referrals 18
4.1.2 Treatment Guidelines 19
5 Competitive Assessment 25
5.1 Overview 25
5.2 Strategic Competitor Assessment 26
6 Apidra (insulin glulisine) 28
6.1 Overview 28
6.2 Efficacy 29
6.3 Safety 29
6.4 SWOT Analysis 30
6.5 Forecast 30
7 Appendix 32
7.1 Bibliography 32
7.2 Abbreviations 35
7.3 Methodology 36
7.4 Forecasting Methodology 36
7.4.1 Diagnosed Type 2 Patients 36
7.4.2 Percent Drug-Treated Patients 37
7.4.3 Drugs Included in Each Therapeutic Class 37
7.4.4 Launch and Patent Expiry Dates 38
7.4.5 General Pricing Assumptions 38
7.4.6 Individual Drug Assumptions 39
7.4.7 Generic Erosion 39
7.5 Physicians and Specialists Included in this Study 40
7.6 About the Authors 42
7.6.1 Analyst II – CVMD 42
7.6.2 Therapy Director – CVMD and Infectious Disease 42
7.6.3 Global Head of Healthcare 43
7.7 About GlobalData 44
7.8 Disclaimer 44